Business description: Ampliphi Biosciences Corp

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. Th Company is engaged in developing and advancing a pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Its two lead candidates addresses both chronic and acute bacterial infections. The Company's first lead candidate focused primarily on chronic bacterial infections is the clinical phage candidate for Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.

Sales by Activity: Ampliphi Biosciences Corp

Fiscal Period: December20192020202120222023

Biotechnology

- 823K 4.47M 5.51M 4.53M
See all business segments

Geographical breakdown of sales: Ampliphi Biosciences Corp

Fiscal Period: December20192020202120222023

United States

- 823K 4.47M 5.51M 4.53M
See all geographic segments

Managers: Ampliphi Biosciences Corp

Director TitleAgeSince
Chief Executive Officer 69 2023-07-10
Director of Finance/CFO 41 2024-08-15
Chief Operating Officer - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
See AMPLIPHI BIOSCIENCES CORP governance

Members of the board: Ampliphi Biosciences Corp

Manager TitleAgeSince
Director/Board Member 61 2019-05-08
Director/Board Member 67 2019-10-09
Director/Board Member 65 2020-02-11
Director/Board Member 50 2020-02-11
Chairman 59 -
Chairman 74 2021-05-31
Director/Board Member 69 2023-07-10
Composition of the Board of Directors

Shareholders: Ampliphi Biosciences Corp

NameEquities%Valuation
25,076,769 69.31 % 50 M $
Bank of America, NA (Charlotte, North Carolina)
1.752 %
634,047 1.752 % 1 M $
260,000 0.7186 % 520 000 $
Vanguard Global Advisers LLC
0.647 %
234,119 0.647 % 468 238 $
Geode Capital Management LLC
0.2951 %
106,789 0.2951 % 213 578 $
List of AMPLIPHI BIOSCIENCES CORP shareholders

Company details: Ampliphi Biosciences Corp

Armata Pharmaceuticals, Inc.

5005 McConnell Avenue

90066, Los Angeles

+

http://www.armatapharma.com
address Ampliphi Biosciences Corp(APHB)

Bio Therapeutic Drugs

Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.77%-2.20%+9.84%+98.50% 118B
-0.10%-5.13%-28.93%+8.03% 72.09B
-2.13%-3.83%+68.23%+140.90% 38.79B
-2.40%+1.89%+31.02%-22.46% 28.73B
+2.38%+3.29%+58.26%+12.45% 24.63B
+4.61%+2.25%+11.97%-30.27% 23.61B
-2.06%+6.27%+380.22%+952.71% 15.76B
+0.81%-0.80%+189.03%+244.83% 14.19B
+0.94%+8.59%-19.89%-31.61% 13.46B
Average +0.14%+1.06%+77.75%+152.57% 38.79B
Weighted average by Cap. -0.26%-1.16%+36.48%+99.29%
See all sector performances
  1. Stock Market
  2. Equities
  3. ARMP Stock
  4. APHB Stock
  5. Company Ampliphi Biosciences Corp